Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics. / Nejad, A.B.; Ebdrup, Bjørn Hylsebeck; Glenthøj, Birte Yding; Siebner, Hartwig Roman.

In: Current Neuropharmacology, Vol. 10, No. 3, 09.2012, p. 219-230.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Nejad, AB, Ebdrup, BH, Glenthøj, BY & Siebner, HR 2012, 'Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics', Current Neuropharmacology, vol. 10, no. 3, pp. 219-230. https://doi.org/10.2174/157015912803217305

APA

Nejad, A. B., Ebdrup, B. H., Glenthøj, B. Y., & Siebner, H. R. (2012). Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics. Current Neuropharmacology, 10(3), 219-230. https://doi.org/10.2174/157015912803217305

Vancouver

Nejad AB, Ebdrup BH, Glenthøj BY, Siebner HR. Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics. Current Neuropharmacology. 2012 Sep;10(3):219-230. https://doi.org/10.2174/157015912803217305

Author

Nejad, A.B. ; Ebdrup, Bjørn Hylsebeck ; Glenthøj, Birte Yding ; Siebner, Hartwig Roman. / Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics. In: Current Neuropharmacology. 2012 ; Vol. 10, No. 3. pp. 219-230.

Bibtex

@article{6943b2cfb33c4a27af4369a330dbcb48,
title = "Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics",
abstract = "Impaired brain connectivity is a hallmark of schizophrenia brain dysfunction. However, the effect of drug treatment and challenges on the dysconnectivity of functional networks in schizophrenia is an understudied area. In this review, we provide an overview of functional magnetic resonance imaging studies examining dysconnectivity in schizophrenia and discuss the few studies which have also attempted to probe connectivity changes with antipsychotic drug treatment. We conclude with a discussion of possible avenues for further investigation.",
author = "A.B. Nejad and Ebdrup, {Bj{\o}rn Hylsebeck} and Glenth{\o}j, {Birte Yding} and Siebner, {Hartwig Roman}",
year = "2012",
month = sep,
doi = "10.2174/157015912803217305",
language = "English",
volume = "10",
pages = "219--230",
journal = "Current Neuropharmacology",
issn = "1570-159X",
publisher = "Bentham Science Publishers",
number = "3",

}

RIS

TY - JOUR

T1 - Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics

AU - Nejad, A.B.

AU - Ebdrup, Bjørn Hylsebeck

AU - Glenthøj, Birte Yding

AU - Siebner, Hartwig Roman

PY - 2012/9

Y1 - 2012/9

N2 - Impaired brain connectivity is a hallmark of schizophrenia brain dysfunction. However, the effect of drug treatment and challenges on the dysconnectivity of functional networks in schizophrenia is an understudied area. In this review, we provide an overview of functional magnetic resonance imaging studies examining dysconnectivity in schizophrenia and discuss the few studies which have also attempted to probe connectivity changes with antipsychotic drug treatment. We conclude with a discussion of possible avenues for further investigation.

AB - Impaired brain connectivity is a hallmark of schizophrenia brain dysfunction. However, the effect of drug treatment and challenges on the dysconnectivity of functional networks in schizophrenia is an understudied area. In this review, we provide an overview of functional magnetic resonance imaging studies examining dysconnectivity in schizophrenia and discuss the few studies which have also attempted to probe connectivity changes with antipsychotic drug treatment. We conclude with a discussion of possible avenues for further investigation.

U2 - 10.2174/157015912803217305

DO - 10.2174/157015912803217305

M3 - Journal article

C2 - 23449679

VL - 10

SP - 219

EP - 230

JO - Current Neuropharmacology

JF - Current Neuropharmacology

SN - 1570-159X

IS - 3

ER -

ID: 48454782